JP2023030558A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023030558A5 JP2023030558A5 JP2021135757A JP2021135757A JP2023030558A5 JP 2023030558 A5 JP2023030558 A5 JP 2023030558A5 JP 2021135757 A JP2021135757 A JP 2021135757A JP 2021135757 A JP2021135757 A JP 2021135757A JP 2023030558 A5 JP2023030558 A5 JP 2023030558A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- biomarker
- sleep disorder
- amount
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000090 biomarker Substances 0.000 claims 20
- 208000019116 sleep disease Diseases 0.000 claims 20
- 208000020685 sleep-wake disease Diseases 0.000 claims 20
- 239000003814 drug Substances 0.000 claims 9
- 229940124597 therapeutic agent Drugs 0.000 claims 9
- 210000003296 saliva Anatomy 0.000 claims 8
- 239000000523 sample Substances 0.000 claims 8
- 108700011259 MicroRNAs Proteins 0.000 claims 6
- 238000005259 measurement Methods 0.000 claims 6
- 238000012360 testing method Methods 0.000 claims 6
- 238000000034 method Methods 0.000 claims 4
- 239000002679 microRNA Substances 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 108091086643 Mus musculus miR-466c-1 stem-loop Proteins 0.000 claims 2
- 108091071208 Mus musculus miR-466c-2 stem-loop Proteins 0.000 claims 2
- 108091043883 Mus musculus miR-466c-3 stem-loop Proteins 0.000 claims 2
- 108091057299 Mus musculus miR-6350 stem-loop Proteins 0.000 claims 2
- 108091023647 Mus musculus miR-7043 stem-loop Proteins 0.000 claims 2
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 claims 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 238000007481 next generation sequencing Methods 0.000 claims 1
- 239000002853 nucleic acid probe Substances 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021135757A JP2023030558A (ja) | 2021-08-23 | 2021-08-23 | 唾液中の睡眠障害バイオマーカー |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021135757A JP2023030558A (ja) | 2021-08-23 | 2021-08-23 | 唾液中の睡眠障害バイオマーカー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023030558A JP2023030558A (ja) | 2023-03-08 |
| JP2023030558A5 true JP2023030558A5 (enExample) | 2024-08-13 |
Family
ID=85413951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021135757A Pending JP2023030558A (ja) | 2021-08-23 | 2021-08-23 | 唾液中の睡眠障害バイオマーカー |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2023030558A (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018175422A1 (en) * | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Method for diagnosing or monitoring conditions characterized by abnormal temporal variations method of normalizing epigenetic data to compensate for temporal variations |
-
2021
- 2021-08-23 JP JP2021135757A patent/JP2023030558A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Perez et al. | Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction | |
| JP2015154774A5 (enExample) | ||
| JP2016525355A5 (enExample) | ||
| WO2011032109A1 (en) | Biomarkers for spinal muscular atrophy | |
| JP2012523009A5 (enExample) | ||
| JP2010539490A5 (enExample) | ||
| JP2014528576A5 (enExample) | ||
| JP2011516046A5 (enExample) | ||
| JP2010525332A5 (enExample) | ||
| Kavsak et al. | High-sensitivity cardiac troponin risk cutoffs for acute cardiac outcomes at emergency department presentation | |
| JP2008537474A5 (enExample) | ||
| CN113234829B (zh) | 结肠癌预后评估基因集及其构建方法 | |
| JP2018529931A5 (enExample) | ||
| RU2019103403A (ru) | Адреномедуллин для оценки застоя у индивидуума с острой сердечной недостаточностью | |
| CN119776488A (zh) | 一种心力衰竭的生物标志物及其应用 | |
| Alzahrani et al. | Postmortem genetic testing in sudden unexpected death: a narrative review | |
| Thanigaimani et al. | Association between serum MicroRNAs and abdominal aortic aneurysm diagnosis and growth | |
| TWI571514B (zh) | 評估罹患大腸直腸癌風險的方法 | |
| JP2023030558A5 (enExample) | ||
| US20170145501A1 (en) | Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response | |
| JP2022048190A (ja) | ドライアイ疾患の予後のための遺伝子シグネチャー | |
| CN110809718A (zh) | 利用血液生物标志物诊断肌肉衰弱相关疾病的方法和试剂盒 | |
| JP6401297B2 (ja) | インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法 | |
| JP2023030598A5 (enExample) | ||
| CN113201590A (zh) | 用于评估肝细胞癌早期复发风险的lncRNA、评估方法及装置 |